Minwin F

Product Details

• Active ingredient(s): Minoxidil + Finasteride
• Strength / variation: 5 mg + 1 mg
• Form: Oral tablet
• Brand / marketer: Winlife Pharma

Full Product Description

Minwin F combines Minoxidil + Finasteride in 5 mg + 1 mg. The ingredients act through different pathways: minoxidil can support follicular activity, while the DHT-targeting component reduces formation of dihydrotestosterone.

How the Combination Works

Combination treatment may be used when a clinician considers more than one mechanism relevant to the patient’s hair loss. Because both ingredients are systemic medicines, the safety considerations of each component still apply.

Safety Information

• Oral minoxidil can cause dizziness, fluid retention, swelling, increased heart rate and other systemic effects.
• Finasteride or dutasteride can cause sexual adverse effects and can affect PSA interpretation.
• Pregnancy-exposure precautions apply to finasteride- and dutasteride-containing medicines.
• Do not combine overlapping systemic hair-loss medicines or change strength without medical guidance.

Frequently Asked Questions

Q) Why combine minoxidil with a DHT-targeting medicine?

The ingredients act through different biological pathways, which may be useful in appropriately selected patients.

Q) Is an oral combination the same as a topical combination solution?

No. Oral milligram doses and topical percentage concentrations are different formulations and are not interchangeable.

Q) Does the stronger option always work better?

No. Strength selection should reflect medical assessment, tolerability and individual risk.

Disclaimer

This information is provided for general product education and does not replace diagnosis, prescribing, individualized medical advice, or the instructions supplied with the product. Product availability, labeling and regulatory status can vary by country.